ArticleOpen forum infectious diseases2025
Evaluation of Different Versions of the Duke Criteria for the Diagnosis of Infective Endocarditis Among Patients With Enterococcal Bacteremia; a Multicenter Study.
Article in Open forum infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Article
- Evaluation of the MEFIER Score in Identifying Patients at High Risk of Endocarditis inOpen forum infectious diseases · 2026Article
- Current Management of Infective Endocarditis: A Narrative Review Focused on Unmet Clinical Needs and the Multidisciplinary Approach.Journal of cardiovascular development and disease · 2026Review
- Rethinking the Routine: Are Repeat Blood Cultures Necessary After Completion of Infective Endocarditis Treatment?Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026Article
- Prediction Scores Identifying Patients at High Risk of Endocarditis in Enterococcal Bacteremia.Open forum infectious diseases · 2026Article
- Performance of Different Versions of Duke Criteria in Diagnosing Infective Endocarditis in Patients With Intracardiac Prosthetic Materials.Open forum infectious diseases · 2025Article
- Evaluating Blood Culture Parameters to Identify Patients at Low Risk of Infective Endocarditis Among Those With Bacteremia by Gram-positive Cocci.Open forum infectious diseases · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Enterococci are a common cause of infective endocarditis (IE). This study aimed to assess the diagnostic performance of the 2015 and 2023 Duke versions of the European Society of Cardiology (ESC) Duke criteria, as well as the 2023 Duke International Society of Cardiovascular Infectious Diseases (ISCVID) clinical criteria, for identifying IE among patients with enterococcal bacteremia. Methods: We included adult retrospective patients with enterococcal bacteremia from 3 independent cohorts across 2 Swiss university hospitals between 2015 and 2024. An interdisciplinary Endocarditis Team classified each case as either IE or not IE. Each episode was then classified as definite, possible, or rejected IE according to the 2015 Duke-ESC, 2023 Duke-ESC, and 2023 Duke-ISCVID clinical criteria. Patients with IE (reference standard) classified as definite IE by the Duke criteria were considered true positives, while those without IE classified as rejected IE were considered true negatives. Results: Among 827 episodes with enterococcal bacteremia, IE was diagnosed in 173 (21%) episodes. The sensitivity of the 2015 Duke-ESC, 2023 Duke-ISCVID, and 2023 Duke-ESC clinical criteria for diagnosing IE was 67% (95% CI, 59%-74%), 79% (95% CI, 72%-85%), and 74% (95% CI, 67%-80%), respectively. Specificity was 86% (95% CI, 83%-89%) for the 2015 Duke-ESC criteria, 55% (95% CI, 51%-59%) for the 2023 Duke-ISCVID criteria, and 69% (95% CI, 65%-72%) for the 2023 Duke-ESC criteria. Conclusions: Among the evaluated Duke criteria versions, the 2023 Duke-ISCVID criteria demonstrated the highest sensitivity for diagnosing IE in patients with enterococcal bacteremia. However, this was at the expense of specificity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.